Author:
Chen Yuheng,Ren Xiayang,Dai Yuanyuan,Wang Yanfeng
Funder
Special Research Fund for Central Universities, Peking Union Medical College
Beijing Hope Run Special Fund of Cancer Foundation of China
Publisher
Springer Science and Business Media LLC
Reference48 articles.
1. World Health Organization. Cancer. https://www.who.int/news-room/fact-sheets/detail/cancer (Accessed 10 July 2023).
2. Khongorzul, P., Ling, C. J., Khan, F. U., Ihsan, A. U. & Zhang, J. Antibody–drug conjugates: A comprehensive review. Mol. Cancer Res. 18, 3–19 (2020).
3. Coleman, N., Yap, T. A., Heymach, J. V., Meric-Bernstam, F. & Le, X. Antibody-drug conjugates in lung cancer: Dawn of a new era?. NPJ Precis. Oncol. 7, 5 (2023).
4. Fuentes-Antrás, J., Genta, S., Vijenthira, A. & Siu, L. L. Antibody–drug conjugates: In search of partners of choice. Trends Cancer 9, 339–354 (2023).
5. Fu, Z., Li, S., Han, S., Shi, C. & Zhang, Y. Antibody drug conjugate: The “biological missile” for targeted cancer therapy. Signal Transduct. Target. Ther. 7, 93 (2022).